RADNOR, PA – 10월 30, 2024 – Certara, Inc. 글로벌 바이오시뮬레이션 선두기업(Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Dr. Tong Zhu, FCP, to lead its Clinical Pharmacology and Translational Medicine Group. Dr. Zhu will continue the group’s evolution of their mission to provide optimal clinical pharmacology strategy and quantitative, data-driven approaches to enhance decision-making throughout the drug development lifecycle.
“I am excited to welcome Tong to Certara as the head of our world-renowned Clinical Pharmacology and Translational Medicine Group,” said Fran Brown, PhD, Senior Vice President, Certara Drug Development Solutions. “Her long history in the pharmaceutical industry and expertise in early development, translational medicine, and clinical pharmacology make her the ideal choice to lead this group and continue our commitment to provide scientific rigor and customized development strategy for our industry partners.”
With nearly 25 years of experience specializing in translational medicine, early development, and clinical pharmacology, Dr. Zhu brings a wealth of knowledge in pharmaceutical research and development. Most recently she was responsible for leading Astellas’ Primary Focus strategy in Mitochondria Biology by working globally to help identify and develop innovative drugs targeting mitochondrial biology. In almost 14 years at the company, she held various leadership positions in its Clinical Pharmacology & Exploratory Development division. Before her time at Astellas, Dr. Zhu held positions with increasing responsibilities at Abbott Global Pharmaceutical Research and Development (now AbbVie) on Clinical Pharmacology and Pharmacometrics teams.
“Throughout my pharmaceutical career, I have known Certara as a trusted partner, providing software, solutions, and scientific leadership in drug development,” said Zhu. “I am excited to join Certara as the leader of the Clinical Pharmacology and Translational Medicine team and look forward to contributing to the mission of transforming drug development to accelerate the delivery of medicines that protect and enhance patient lives.”
Certara 소개
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Certara Contact:
Sheila Rocchio
sheila.rocchio@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com